Home Therapy in Connecticut

Elidah manufactures Elitone, an FDA-cleared, non-invasive wearable medical device for home treatment of stress, urge, and mixed urinary incontinence in women. The device delivers neuromuscular stimulation to the pelvic floor muscles, addressing the root cause of bladder leaks rather than managing symptoms. Clinical studies demonstrate that 95% of users report reduced leaks within 6 weeks. Discreetly worn under clothing for 20 minutes daily, Elitone offers a non-surgical alternative to pads, medications, and invasive procedures. The device is available over-the-counter without prescription, is Medicare and HSA/FSA eligible, and includes a 100% money-back guarantee. Targeted at the estimated 1 in 3 women experiencing bladder leaks.

ZetrOZ Systems is a FDA-cleared medical device manufacturer specializing in wearable bioelectronic devices for sustained acoustic medicine (SAM®). Based in Trumbull, Connecticut and founded in 2008, the company develops non-invasive, battery-powered ultrasound therapy systems designed to accelerate tissue healing and manage pain in chronic musculoskeletal conditions. Their proprietary OZ Inside™ technology enables miniaturized, flexible ultrasound delivery for extended treatment sessions. The SAM® product line treats conditions including knee osteoarthritis, chronic back pain, and tendon injuries through low-intensity, long-duration ultrasound proven to promote healing rather than symptom relief alone. ZetrOZ holds 46 patents and manufactures all products in the USA across four domestic facilities. The company collaborates with federal agencies (NIH, NASA, DOD), sports medicine organizations (USA Field Hockey, National Basketball Trainers Association), and healthcare providers. Devices are used in clinical settings and target sports medicine, orthopedic recovery, and workers' compensation applications.

ROM Technologies, Inc. (ROMTech) is a medical technology company specializing in patented rehabilitation devices and telemedicine solutions for orthopedic and cardiac care. The company's flagship product, PortableConnect®, is a clinician-controlled medical device that delivers physical therapy sessions to patients at home, enabling accelerated recovery for those recovering from total knee replacement, total hip replacement, ACL repairs, and other arthroscopic procedures. ROMTech's telemedicine platform allows patients to begin therapeutic motion as early as the day of surgery, achieving range of motion recovery in approximately half the time of traditional physical therapy. Clinical outcomes demonstrate that PortableConnect patients meet or exceed pre-operative range of motion by 2 weeks post-surgery, with significant reductions in pain, narcotic usage, and hospital readmissions. The technology delivers substantial cost savings of $2,000–$6,250 per patient by reducing acute rehabilitation stays, home health visits, and outpatient therapy sessions while improving clinical outcomes. ROMTech has served over 90,000 patients nationally and has been recognized by Fast Company's 2025 Most Innovative Companies list and LexisNexis' Top 100 Global Innovators for 2026.

CRYON-X LLC manufactures iceless cold therapy devices with integrated compression and heat therapy capabilities. The company specializes in portable, rechargeable cryotherapy systems designed for clinical and home recovery applications. CRYON-X devices deliver temperatures as low as 34°F with real-time temperature monitoring, programmable compression therapy, and integrated heat functions. The product line includes three primary models: Cryon-X Pro (clinical-grade cold/heat therapy unit with real-time monitoring), Cryon-X One (cold compression therapy unit with advanced temperature management), and Cryon-X Go (portable contrast therapy unit for on-the-go use). Key clinical applications include post-operative recovery, acute injury management, sports medicine, physical rehabilitation, and long-term home therapy. The devices are designed to eliminate traditional ice packs while providing superior thermal efficiency—reportedly three times more efficient than conventional systems. All CRYON-X devices are FDA-cleared Class II medical devices, meeting rigorous regulatory standards for clinical use. The company serves surgeons, sports medicine specialists, physical therapists, recovery specialists, and surgical teams across the United States, with international distribution through regional partners.

MannKind Corporation is a biopharmaceutical company focused on innovative drug delivery technologies, particularly inhaled therapies for chronic diseases. Founded in 1991 and headquartered in Danbury, Connecticut, MannKind specializes in treatments for cardiometabolic diseases, orphan lung diseases, pulmonary hypertension, and fluid overload in heart and chronic kidney disease. The company utilizes its proprietary Technosphere® platform for pulmonary drug delivery. Key marketed products include Afrezza® (inhaled insulin for diabetes), V-Go® (all-in-one insulin delivery patch), FUROSCIX® (furosemide injection for fluid overload), and Tyvaso DPI® (treprostinil inhalation powder for pulmonary hypertension, utilizing Technosphere technology under partnership with United Therapeutics). MannKind is committed to enhancing patient outcomes through transformative therapies and ongoing clinical development across endocrine and orphan lung disease indications.

TrumedX LLC is a durable medical equipment manufacturer and distributor specializing in post-operative and injury recovery solutions. The company manufactures four primary product lines: cold compression therapy (CCT) systems for swelling and pain reduction, electrical muscle stimulation (EMS) devices for targeted muscle strength restoration, orthopedic bracing products for joint support and stabilization, and deep vein thrombosis (DVT) prevention devices for blood clot prophylaxis during recovery periods. These devices are marketed to both clinical and homecare settings, targeting patients recovering from injury or surgery who require non-pharmacological pain management and functional support. The product portfolio addresses common post-operative complications and pain management needs in rehabilitation and physical therapy contexts. TrumedX operates a distributor network model, actively recruiting partners to expand market reach. The company positions itself as a provider of evidence-based recovery solutions with a focus on enabling faster return to normal daily activities and reducing recovery duration through evidence-supported modalities.